Introducing Regnitio

Helping medicines developers and their investors navigate the European regulatory landscape

Who are we?

Regnitio is a consultancy focussing on the regulatory and methodological challenges within medicines development. We base ourselves on three core principles - solving problems, informing decisions and achieving consensus.

Whether it is:

  • interpreting regulatory assessment questions or guidelines and formulating strategy to address them;
  • building consensus within teams or between regulatory regions;
  • providing an independent view on proposed development plans,

Regnitio can deliver unique insights that help bring safe and effective medicines to patients faster.

Why choose Regnitio?
 
With over 18 years of regulatory experience at the national and international level, Dr Andrew Thomson, Regnitio's lead consultant, has unparalleled experience focussing on the design, analysis and interpretation of clinical trials through a methodological lens.

Contact:

andrew@regnitio.com

LinkedIn

+31611791310

Created using WordPress and SeedProd. Logo by Calico Creative